About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
OncoImmunology
›
top-articles
OncoImmunology
5.5
(top 5%)
impact factor
3.4K
(top 5%)
papers
103.0K
(top 5%)
citations
115
(top 5%)
h
-index
5.8
(top 5%)
impact factor
3.6K
all documents
113.4K
doc citations
160
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Consensus guidelines for the detection of immunogenic cell death
OncoImmunology
2014
686
2
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
OncoImmunology
2016
545
3
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
OncoImmunology
2014
439
4
Role of IL-2 in cancer immunotherapy
OncoImmunology
2016
347
5
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
OncoImmunology
2012
338
6
IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors
in vivo
OncoImmunology
2015
336
7
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
OncoImmunology
2014
318
8
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
OncoImmunology
2012
315
9
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8
+
T cells
OncoImmunology
2013
311
10
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
OncoImmunology
2017
305
11
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
OncoImmunology
2017
252
12
TIM3
+
FOXP3
+
regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
OncoImmunology
2013
251
13
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer
OncoImmunology
2016
247
14
First oncolytic virus approved for melanoma immunotherapy
OncoImmunology
2016
247
15
The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
OncoImmunology
2017
247
16
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes
OncoImmunology
2018
247
17
Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands
OncoImmunology
2012
246
18
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
OncoImmunology
2018
243
19
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases
OncoImmunology
2016
239
20
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
OncoImmunology
2015
238
21
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
OncoImmunology
2015
237
22
Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer
OncoImmunology
2017
235
23
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
OncoImmunology
2015
227
24
Trial watch: IDO inhibitors in cancer therapy
OncoImmunology
2014
223
25
Targeting CD73 in the tumor microenvironment with MEDI9447
OncoImmunology
2016
221
26
Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy
OncoImmunology
2015
219
27
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
OncoImmunology
2018
219
28
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
OncoImmunology
2018
217
29
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
OncoImmunology
2013
216
30
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
OncoImmunology
2017
209
31
Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
OncoImmunology
2017
209
32
The IRF family of transcription factors
OncoImmunology
2012
205
33
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
OncoImmunology
2017
205
34
Interaction of tumor-associated macrophages and cancer chemotherapy
OncoImmunology
2019
205
35
Are natural killer cells superior CAR drivers?
OncoImmunology
2014
204
36
Trial watch
OncoImmunology
2012
203
37
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
OncoImmunology
2018
200
38
Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease
OncoImmunology
2012
199
39
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
OncoImmunology
2015
195
40
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
OncoImmunology
2012
194
41
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
OncoImmunology
2017
193
42
A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab
OncoImmunology
2015
191
43
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
OncoImmunology
2017
190
44
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
OncoImmunology
2015
189
45
Priming of neutrophils toward NETosis promotes tumor growth
OncoImmunology
2016
188
46
Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis
OncoImmunology
2019
187
47
Trial Watch
OncoImmunology
2012
184
48
Eosinophils: The unsung heroes in cancer?
OncoImmunology
2018
184
49
Neutrophil extracellular traps
OncoImmunology
2013
181
50
The exosomes in tumor immunity
OncoImmunology
2015
181
site/software ©
exaly
; All materials licenced under
CC by-SA
.